Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-014747
Filing Date
2012-03-06
Accepted
2012-03-06 16:28:22
Documents
1
Period of Report
2012-03-02

Document Format Files

Seq Description Document Type Size
1 LARRY H 3-6-12 rrd337493.html 4  
1 LARRY H 3-6-12 rrd337493.xml 4 3229
  Complete submission text file 0001181431-12-014747.txt   4595
Mailing Address 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACELRX PHARMACEUTICALS INC. 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address
Hamel Lawrence G (Reporting) CIK: 0001511368 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 12670717